68974-400 : Filspari 400 mg Oral Tablet, Film Coated
NDC: | 68974-400 |
Labeler: | Travere Therapeutics, Inc. |
Product Type: | Human Prescription Drug |
Drug Name: | Filspari |
Dosage Form: | Oral Tablet, Film Coated |
Application #: | NDA216403 |
Rev. Date: |
NDC Package Codes:
- 68974-400-30: 30 TABLET, FILM COATED IN 1 BOTTLE (68974‑400‑30)
Active Ingredients:
- Sparsentan
Dosage Strength:
- 400 mg
Pharmaceutical Classes:
- Angiotensin 2 Receptor Blocker [EPC]
- Angiotensin 2 Type 1 Receptor Antagonists [MoA]
- Breast Cancer Resistance Protein Inhibitors [MoA]
- Cytochrome P450 2B6 Inducers [MoA]
- Cytochrome P450 2C19 Inducers [MoA]
- Cytochrome P450 2C9 Inducers [MoA]
- Endothelin Receptor Antagonist [EPC]
- Endothelin Receptor Antagonists [MoA]
- P-Glycoprotein Inhibitors [MoA]
Related Products:
Based on records with the same trade name.- 68974-200 Filspari 200 mg Oral Tablet, Film Coated by Travere Therapeutics, Inc.
NDC QR Code
Scan the QR code below to easily reference this data in the future:< Prev: 68974-200Next: 68974-876 >
Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.